The Antiemetic Drugs Market is expected to register a CAGR of 6.3% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Antiemetic Drugs Market report covers analysis by Drug Type (5-HT3 Receptor Antagonists, Dopamine Antagonists, NK1 Receptor Antagonist, Antihistamines, Cannabinoids, Benzodiazepines, Anticholinergics, Others); Application (Chemotherapy, Motion Sickness, Gastroenteritis, Opioid Analgesics, Dizziness, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Antiemetic Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antiemetic Drugs Market Segmentation
Drug Type- 5-HT3 Receptor Antagonists
- Dopamine Antagonists
- NK1 Receptor Antagonist
- Antihistamines
- Cannabinoids
- Benzodiazepines
- Anticholinergics
- Chemotherapy
- Motion Sickness
- Gastroenteritis
- Opioid Analgesics
- Dizziness
Strategic Insights
Antiemetic Drugs Market Growth Drivers- Increasing Frequence of Acute Nausea and Vomiting Disorders: These increased spells of disorders such as motion sickness, nausea, and vomiting due to a chemotherapeutic agent (CINV), gastrointestinal disorders, and nausea associated with pregnancy may account for one of the most significant factors to the antiemetic drugs market. With the rise of the incidences, the demands for available antiemetics will rise, especially in cases concerning cancer and pregnancy.
- Emerging Cancerous and Chemotherapy Treatments: The rising demand for antiemetic drugs in the management of chemotherapy-induced nausea and vomiting (CINV) is blown out by the continued increase in cancer diagnoses worldwide. Such advances in chemotherapy treatments are usually accompanied by side effects such as nausea and vomiting, increasing the demand for drugs to control these symptoms and thus the quality of life in cancer patients.
- Increasing Use of Antiemetics for Pregnancy and Motion Sickness: Antiemetics are consumed traditionally for nausea during pregnancy and motion sickness. Pregnancies and traveling are increasing, consequently increasing the demand for this therapy. Interestingly, several safer formulations for pregnant women have opened another growing space in the antiemetics market.
- Shift towards Targeted Therapies: A major trend observed is the development of targeted antiemetic therapy, which acts on specific receptors implicated in various pathways of nausea and vomiting. NK1 receptor antagonists and 5-HT3 antagonists are increasingly used because they are more efficient and well-targeted than classical antiemetics, with fewer side effects.
- Going for Combination Therapies: An increasing trend is being witnessed in the combination therapy arena to provide a better means to control nausea and vomiting. Combination antiemetic regimens encompassing drugs from various classes, such as serotonin antagonists and corticosteroids, are now widely used in CINV and otherwise, providing better symptom control and patient outcomes.
- Rise of Over-the-counter (OTC) Medication: The availability of OTC antiemetic drugs for motion sickness or morning sickness is on the rise. This shift towards self-medication is spurred by increasing customer awareness and greater access. It further extends the market by providing options for patients to manage milder forms of nausea and vomiting.
- Use of Antiemetics for Other Medical Conditions: Antiemetics are being used primarily in cancer therapy, treating motion sickness, and for obstetric care but there is an interest in exploring their use in treating other medical conditions such as gastroparesis, viral infections, and postoperative nausea. For these new indications, there exist unexplored opportunities that widen the scope of antiemetic use.
- Research on Pediatric Nausea and Vomiting: Nausea and vomiting in children can be a challenge because of gastroenteritis, chemotherapy, or motion sickness. This presents a marketing opportunity for developing safe and effective antiemetics for the pediatric market. This area allows those companies working in the pediatric space to capitalize on an underdeveloped market.
- Sustainable and Eco-friendly Drug Development: There is an opportunity for developing environmentally friendly antiemetic preparations with a reduced environmental impact as more and more patients and healthcare providers are demanding the use of sustainable products. Biodegradable formulation and eco-friendly packaging are becoming prominent considerations in formulating newer therapies, providing an opportunity for differentiation in the marketplace.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antiemetic Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antiemetic Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Antiemetic Drugs Market are Increasing Frequence of Acute Nausea and Vomiting Disorders, Emerging Cancerous and Chemotherapy Treatments, and Increasing Use of Antiemetics for Pregnancy and Motion Sickness
The key future trends of the market are Shift towards Targeted Therapies, Going for Combination Therapies, and Rise of Over-the-counter (OTC) Medication
The leading players operating in the Antiemetic Drugs Market include GLAXOSMITHKLINE PHARMACEUTICALS LIMITED, JOHNSON AND JOHNSON, SANOFI, MERCK AND CO., NOVARTIS AG, BRISTOL-MYERS SQUIBB, ASTELLAS PHARMA, INC., ELI LILLY AND COMPANY, ABBOTT, CIPLA LTD., DR. REDDY'S LABORATORIES LD
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antiemetic Drugs Market - By Drug Type
1.3.2 Antiemetic Drugs Market - By Application
1.3.3 Antiemetic Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIEMETIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIEMETIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIEMETIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIEMETIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTIEMETIC DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIEMETIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. 5-HT3 RECEPTOR ANTAGONISTS
7.3.1. Overview
7.3.2. 5-HT3 Receptor Antagonists Market Forecast and Analysis
7.4. DOPAMINE ANTAGONISTS
7.4.1. Overview
7.4.2. Dopamine Antagonists Market Forecast and Analysis
7.5. NK1 RECEPTOR ANTAGONIST
7.5.1. Overview
7.5.2. NK1 Receptor Antagonist Market Forecast and Analysis
7.6. ANTIHISTAMINES
7.6.1. Overview
7.6.2. Antihistamines Market Forecast and Analysis
7.7. CANNABINOIDS
7.7.1. Overview
7.7.2. Cannabinoids Market Forecast and Analysis
7.8. BENZODIAZEPINES
7.8.1. Overview
7.8.2. Benzodiazepines Market Forecast and Analysis
7.9. ANTICHOLINERGICS
7.9.1. Overview
7.9.2. Anticholinergics Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis
8. ANTIEMETIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CHEMOTHERAPY
8.3.1. Overview
8.3.2. Chemotherapy Market Forecast and Analysis
8.4. MOTION SICKNESS
8.4.1. Overview
8.4.2. Motion Sickness Market Forecast and Analysis
8.5. GASTROENTERITIS
8.5.1. Overview
8.5.2. Gastroenteritis Market Forecast and Analysis
8.6. OPIOID ANALGESICS
8.6.1. Overview
8.6.2. Opioid Analgesics Market Forecast and Analysis
8.7. DIZZINESS
8.7.1. Overview
8.7.2. Dizziness Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. ANTIEMETIC DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antiemetic Drugs Market Overview
9.1.2 North America Antiemetic Drugs Market Forecasts and Analysis
9.1.3 North America Antiemetic Drugs Market Forecasts and Analysis - By Drug Type
9.1.4 North America Antiemetic Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Antiemetic Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antiemetic Drugs Market
9.1.5.1.1 United States Antiemetic Drugs Market by Drug Type
9.1.5.1.2 United States Antiemetic Drugs Market by Application
9.1.5.2 Canada Antiemetic Drugs Market
9.1.5.2.1 Canada Antiemetic Drugs Market by Drug Type
9.1.5.2.2 Canada Antiemetic Drugs Market by Application
9.1.5.3 Mexico Antiemetic Drugs Market
9.1.5.3.1 Mexico Antiemetic Drugs Market by Drug Type
9.1.5.3.2 Mexico Antiemetic Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Antiemetic Drugs Market Overview
9.2.2 Europe Antiemetic Drugs Market Forecasts and Analysis
9.2.3 Europe Antiemetic Drugs Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Antiemetic Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Antiemetic Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antiemetic Drugs Market
9.2.5.1.1 Germany Antiemetic Drugs Market by Drug Type
9.2.5.1.2 Germany Antiemetic Drugs Market by Application
9.2.5.2 France Antiemetic Drugs Market
9.2.5.2.1 France Antiemetic Drugs Market by Drug Type
9.2.5.2.2 France Antiemetic Drugs Market by Application
9.2.5.3 Italy Antiemetic Drugs Market
9.2.5.3.1 Italy Antiemetic Drugs Market by Drug Type
9.2.5.3.2 Italy Antiemetic Drugs Market by Application
9.2.5.4 Spain Antiemetic Drugs Market
9.2.5.4.1 Spain Antiemetic Drugs Market by Drug Type
9.2.5.4.2 Spain Antiemetic Drugs Market by Application
9.2.5.5 United Kingdom Antiemetic Drugs Market
9.2.5.5.1 United Kingdom Antiemetic Drugs Market by Drug Type
9.2.5.5.2 United Kingdom Antiemetic Drugs Market by Application
9.2.5.6 Rest of Europe Antiemetic Drugs Market
9.2.5.6.1 Rest of Europe Antiemetic Drugs Market by Drug Type
9.2.5.6.2 Rest of Europe Antiemetic Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antiemetic Drugs Market Overview
9.3.2 Asia-Pacific Antiemetic Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Antiemetic Drugs Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Antiemetic Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Antiemetic Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antiemetic Drugs Market
9.3.5.1.1 Australia Antiemetic Drugs Market by Drug Type
9.3.5.1.2 Australia Antiemetic Drugs Market by Application
9.3.5.2 China Antiemetic Drugs Market
9.3.5.2.1 China Antiemetic Drugs Market by Drug Type
9.3.5.2.2 China Antiemetic Drugs Market by Application
9.3.5.3 India Antiemetic Drugs Market
9.3.5.3.1 India Antiemetic Drugs Market by Drug Type
9.3.5.3.2 India Antiemetic Drugs Market by Application
9.3.5.4 Japan Antiemetic Drugs Market
9.3.5.4.1 Japan Antiemetic Drugs Market by Drug Type
9.3.5.4.2 Japan Antiemetic Drugs Market by Application
9.3.5.5 South Korea Antiemetic Drugs Market
9.3.5.5.1 South Korea Antiemetic Drugs Market by Drug Type
9.3.5.5.2 South Korea Antiemetic Drugs Market by Application
9.3.5.6 Rest of Asia-Pacific Antiemetic Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Antiemetic Drugs Market by Drug Type
9.3.5.6.2 Rest of Asia-Pacific Antiemetic Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antiemetic Drugs Market Overview
9.4.2 Middle East and Africa Antiemetic Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Antiemetic Drugs Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Antiemetic Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Antiemetic Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antiemetic Drugs Market
9.4.5.1.1 South Africa Antiemetic Drugs Market by Drug Type
9.4.5.1.2 South Africa Antiemetic Drugs Market by Application
9.4.5.2 Saudi Arabia Antiemetic Drugs Market
9.4.5.2.1 Saudi Arabia Antiemetic Drugs Market by Drug Type
9.4.5.2.2 Saudi Arabia Antiemetic Drugs Market by Application
9.4.5.3 U.A.E Antiemetic Drugs Market
9.4.5.3.1 U.A.E Antiemetic Drugs Market by Drug Type
9.4.5.3.2 U.A.E Antiemetic Drugs Market by Application
9.4.5.4 Rest of Middle East and Africa Antiemetic Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Antiemetic Drugs Market by Drug Type
9.4.5.4.2 Rest of Middle East and Africa Antiemetic Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antiemetic Drugs Market Overview
9.5.2 South and Central America Antiemetic Drugs Market Forecasts and Analysis
9.5.3 South and Central America Antiemetic Drugs Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Antiemetic Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Antiemetic Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antiemetic Drugs Market
9.5.5.1.1 Brazil Antiemetic Drugs Market by Drug Type
9.5.5.1.2 Brazil Antiemetic Drugs Market by Application
9.5.5.2 Argentina Antiemetic Drugs Market
9.5.5.2.1 Argentina Antiemetic Drugs Market by Drug Type
9.5.5.2.2 Argentina Antiemetic Drugs Market by Application
9.5.5.3 Rest of South and Central America Antiemetic Drugs Market
9.5.5.3.1 Rest of South and Central America Antiemetic Drugs Market by Drug Type
9.5.5.3.2 Rest of South and Central America Antiemetic Drugs Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIEMETIC DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIEMETIC DRUGS MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JOHNSON AND JOHNSON
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK AND CO.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVARTIS AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BRISTOL-MYERS SQUIBB
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASTELLAS PHARMA, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ELI LILLY AND COMPANY
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ABBOTT, CIPLA LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DR. REDDY’S LABORATORIES LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
2. JOHNSON AND JOHNSON
3. SANOFI
4. MERCK AND CO.
5. NOVARTIS AG
6. BRISTOL-MYERS SQUIBB
7. ASTELLAS PHARMA, INC.
8. ELI LILLY AND COMPANY
9. ABBOTT
10. DR. REDDY'S LABORATORIES LTD
11. Pfizer
12. Baxter International
13. Cipla Ltd.
14. LGM Pharma
15. ZETA PHARMA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For